ArticleCurrent medicinal chemistry2026

DDX59-AS1: A Novel Prognostic Biomarker and Immunotherapy Predictor in Lung Adenocarcinoma.

Yanli Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.